FOLH1 and neuroendocrine neoplasm: The half-life of 68Ga (68 min) mirrors the pharmacokinetics of many well-known peptides and molecules owing to their fast clearance from the blood its biggest impact thus far has been in the imaging of neuroendocrine tumours (107) (when radiolabelled to a somatostatin analogue) and recently with the ligand prostate-specific membrane antigen (PSMA) (108).